BioCentury
ARTICLE | Company News

Cepheid sales and marketing update

March 30, 2009 7:00 AM UTC

Cepheid will launch its Xpert MTB/RIF test in Europe next month to diagnose Mycobacterium tuberculosis (TB) infection and determine its susceptibility to rifampicin. The test will run on Cepheid's Gen...